new data from Galderma’s acne and sensitive skin product portfolio
With 22 presentations in total, the extent and range of data to be shared underscore the pace of Galderma’s growth journey, which AAD attendees can further explore at booth #2021

ZUG, Switzerland--(BUSINESS WIRE)--Galderma will present updates from across its broad dermatology portfolio at the 2025 American Academy of Dermatology (AAD) Annual Meeting, taking place from March 7-11, 2025 in Orlando, Florida. The company will present 22 e-posters – including two oral presentations – with updates on a number of its innovative products, including Nemluvio, Sculptra, Restylane and Relfydess. These presentations combined reinforce the strength of Galderma’s growth journey, its status as the pure-play category leader in dermatology, and its innovative pipeline.

“We’re bringing impactful new science to this year’s AAD meeting, with new data on Nemluvio – our treatment for pru
=*=*=*=*=*=
当前为第2/13页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页